Dominique Thoraval

Title: **Dominique Thoraval: A Pioneer in Antiviral Innovations**

Introduction

Dominique Thoraval is an accomplished inventor based in Candiac, Canada, known for her significant contributions to the field of antiviral research. With a total of seven patents to her name, Thoraval has established herself as a leading figure in the development of pharmaceutical compounds aimed at combating viral infections, particularly HIV.

Latest Patents

Thoraval's most recent invention focuses on the "Salts of prodrugs of piperazine and substituted piperidine antiviral agents." This innovative work provides for prodrug Compounds I, which are essential in the formulation of pharmaceutical compositions intended for the treatment of HIV infection. Furthermore, the invention also details the provision of intermediate Compounds II that are useful in the synthesis of prodrug Compounds I, indicating the depth of her research and the potential impact on antiviral therapies.

Career Highlights

Throughout her career, Dominique Thoraval has worked with respected companies in the pharmaceutical sector, including Bristol-Myers Squibb Company and Her Majesty the Queen in Right of Canada, as represented by the Minister. Her experiences at these organizations have bolstered her expertise and provided her with a platform to innovate within the realm of antiviral medications.

Collaborations

Thoraval has collaborated with prominent professionals such as Yasutsugu Ueda and Timothy P Connolly. Working alongside accomplished individuals in her field, she has expanded her knowledge base and contributed to the collective advancement of pharmaceutical science.

Conclusion

In summary, Dominique Thoraval stands out as a remarkable inventor whose work has far-reaching implications in the fight against viral infections. With her seven patents and ongoing commitment to research, she continues to pave the way for innovative treatments that hold promise for patients suffering from HIV and other viral diseases.